Your browser doesn't support javascript.
loading
The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2-GATA4 Signaling Pathway.
Shimizu, Kana; Sunagawa, Yoichi; Funamoto, Masafumi; Honda, Hiroki; Katanasaka, Yasufumi; Murai, Noriyuki; Kawase, Yuto; Hirako, Yuta; Katagiri, Takahiro; Yabe, Harumi; Shimizu, Satoshi; Sari, Nurmila; Wada, Hiromichi; Hasegawa, Koji; Morimoto, Tatsuya.
Afiliación
  • Shimizu K; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Sunagawa Y; National Hospital Organization Kyoto Medical Center, Division of Translational Research, Kyoto 612-8555, Japan.
  • Funamoto M; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Honda H; National Hospital Organization Kyoto Medical Center, Division of Translational Research, Kyoto 612-8555, Japan.
  • Katanasaka Y; Shizuoka General Hospital, Shizuoka 420-8527, Japan.
  • Murai N; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Kawase Y; National Hospital Organization Kyoto Medical Center, Division of Translational Research, Kyoto 612-8555, Japan.
  • Hirako Y; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Katagiri T; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Yabe H; National Hospital Organization Kyoto Medical Center, Division of Translational Research, Kyoto 612-8555, Japan.
  • Shimizu S; Shizuoka General Hospital, Shizuoka 420-8527, Japan.
  • Sari N; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Wada H; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Hasegawa K; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Morimoto T; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Pharmaceuticals (Basel) ; 14(12)2021 Dec 05.
Article en En | MEDLINE | ID: mdl-34959669
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza